While gene therapies offer the potential for permanent cures, the high price tags for these one-time treatments often exceed three million dollars, creating an unprecedented economic crisis for families. This financial burden marks a departure from traditional medicine, where chronic conditions
Even after adjusting for age and prior therapy lines, metaplastic histology remains a clear indicator of a poor response to the Trop-2-directed antibody-drug conjugate sacituzumab govitecan. This finding, derived from a comprehensive retrospective analysis at the Massachusetts General Hospital
For years, surgeons have treated the neck primarily as a structural corridor or a gateway for life-saving cancer interventions, unaware that this narrow passage also functions as the brain's essential metabolic exhaust pipe. A groundbreaking study from Weill Cornell Medicine has revealed that
Introduction The landscape of neurological medicine is shifting rapidly as the U.S. Food and Drug Administration accelerates its evaluation of a potential breakthrough that could redefine how patients manage multiple sclerosis. This news centers on fenebrutinib, an investigational oral therapy that
The discovery of a germline mutation in a prostate cancer patient facilitates cascade testing for family members who may be at risk for breast, pancreatic, or ovarian cancers. This clinical reality highlights the expanding role of genetic identification as a cornerstone of modern oncology, moving
The appointment of industry veterans from Bristol Myers Squibb and Iovance Biotherapeutics highlights a major transition toward clinical-stage operations for cell therapy developers. This leadership influx comes at a pivotal moment for Link Cell Therapies as it progresses into the Phase I clinical
